VEGFA and colorectal cancer: Therefore, the finding that aberrant splicing of a translation regulator can modulate differential expression of VEGFA variants certainly adds a new layer of complexity to the angiogenic profile of colorectal cancer and their resistance to antiangiogenic therapy [60].